Roemer Alan S.

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 31% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Roemer Alan S.'s trades of Neximmune Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-22 2023-11-22
US Neximmune Inc (NEXI)
PrS Proposed sale
77,608
33.01
US$931,297 		77,608 33.01 US$931,297
2023-11-22 2023-11-22
US Neximmune Inc (NEXI)
S Sale
83,733 -48.7%
482.46
US$2,696,092 		83,733 -48.7% 482.46 US$2,696,092
2023-11-22 2023-11-21
US Neximmune Inc (NEXI)
PrS Proposed sale
61,427
406.38
US$1,586,900 		61,427 406.38 US$1,586,900
2023-11-22 2023-11-21
US Neximmune Inc (NEXI)
S Sale
3,833 -49.0%
2.16
US$8,287 		3,833 -49.0% 2.16 US$8,287
2023-11-21 2023-11-21
US Neximmune Inc (NEXI)
PrS Proposed sale
7,825
2.09
US$16,354 		7,825 2.09 US$16,354
2022-08-18 2022-08-16
US IN8BIO, Inc. (INAB)
B Purchase
26,315 +88.7%
1.90
US$49,998 		26,315 +88.7% 1.90 US$49,998